Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.230
+0.040 (1.83%)
At close: Jan 17, 2025, 4:00 PM
2.200
-0.030 (-1.35%)
After-hours: Jan 17, 2025, 7:50 PM EST
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -70.99% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for OTLK stock have an average target of 23.08, with a low estimate of 9.00 and a high estimate of 33. The average target predicts an increase of 934.98% from the current stock price of 2.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OTLK stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +438.12% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | Jan 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 2, 2024 |
| BTIG | BTIG | Strong Buy Maintains $50 → $9 | Strong Buy | Maintains | $50 → $9 | +303.59% | Nov 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,245.29% | Nov 29, 2024 |
Financial Forecast
Revenue This Year
8.36M
Revenue Next Year
58.87M
from 8.36M
Increased by 603.93%
EPS This Year
-2.51
from -4.06
EPS Next Year
-0.42
from -2.51
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.8M | 76.7M | 358.1M | ||
| Avg | 8.4M | 58.9M | 200.0M | ||
| Low | n/a | 48.2M | 95.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 816.5% | 508.2% | ||
| Avg | - | 603.9% | 239.7% | ||
| Low | - | 476.5% | 62.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.72 | -0.43 | 1.23 | ||
| Avg | -2.51 | -0.42 | 1.19 | ||
| Low | -3.19 | -0.40 | 1.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.